BioInfra Co., Ltd. (KOSDAQ:199730)

BioInfra Statistics

Total Valuation

BioInfra has a market cap or net worth of KRW 19.14 billion. The enterprise value is 22.83 billion.

Market Cap	19.14B
Enterprise Value	22.83B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Dec 29, 2025

Share Statistics

BioInfra has 4.86 million shares outstanding. The number of shares has increased by 0.33% in one year.

Current Share Class	4.86M
Shares Outstanding	4.86M
Shares Change (YoY)	+0.33%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	51.38%
Owned by Institutions (%)	n/a
Float	2.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.83
PB Ratio	1.16
P/TBV Ratio	1.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.50
EV / Sales	0.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.08

Financial Position

The company has a current ratio of 0.69, with a Debt / Equity ratio of 0.72.

Current Ratio	0.69
Quick Ratio	0.57
Debt / Equity	0.72
Debt / EBITDA	n/a
Debt / FCF	-4.20
Interest Coverage	-17.09

Financial Efficiency

Return on equity (ROE) is -41.45% and return on invested capital (ROIC) is -28.94%.

Return on Equity (ROE)	-41.45%
Return on Assets (ROA)	-10.31%
Return on Invested Capital (ROIC)	-28.94%
Return on Capital Employed (ROCE)	-36.29%
Weighted Average Cost of Capital (WACC)	5.43%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.61
Inventory Turnover	n/a

Taxes

In the past 12 months, BioInfra has paid 1.01 billion in taxes.

Income Tax	1.01B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.70% in the last 52 weeks. The beta is 0.55, so BioInfra's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-38.70%
50-Day Moving Average	4,203.80
200-Day Moving Average	4,918.58
Relative Strength Index (RSI)	46.96
Average Volume (20 Days)	11,551

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioInfra had revenue of KRW 23.15 billion and -9.13 billion in losses. Loss per share was -1,877.00.

Revenue	23.15B
Gross Profit	5.23B
Operating Income	-6.28B
Pretax Income	-8.13B
Net Income	-9.13B
EBITDA	-2.84B
EBIT	-6.28B
Loss Per Share	-1,877.00

Balance Sheet

The company has 8.17 billion in cash and 11.86 billion in debt, with a net cash position of -3.69 billion or -757.69 per share.

Cash & Cash Equivalents	8.17B
Total Debt	11.86B
Net Cash	-3.69B
Net Cash Per Share	-757.69
Equity (Book Value)	16.49B
Book Value Per Share	3,389.34
Working Capital	-5.54B

Cash Flow

In the last 12 months, operating cash flow was -1.50 billion and capital expenditures -1.32 billion, giving a free cash flow of -2.82 billion.

Operating Cash Flow	-1.50B
Capital Expenditures	-1.32B
Depreciation & Amortization	3.44B
Net Borrowing	2.03B
Free Cash Flow	-2.82B
FCF Per Share	-580.50

Margins

Gross margin is 22.59%, with operating and profit margins of -27.12% and -39.45%.

Gross Margin	22.59%
Operating Margin	-27.12%
Pretax Margin	-35.10%
Profit Margin	-39.45%
EBITDA Margin	-12.28%
EBIT Margin	-27.12%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 7.41%.

Dividend Per Share	300.00
Dividend Yield	7.41%
Dividend Growth (YoY)	-25.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.33%
Shareholder Yield	7.08%
Earnings Yield	-47.70%
FCF Yield	-14.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioInfra has an Altman Z-Score of 1.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.01
Piotroski F-Score	2